Literature DB >> 10783304

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis.

I B Weinstein1.   

Abstract

The multistage process of carcinogenesis involves the progressive acquisition of mutations, and epigenetic abnormalities in the expression, of multiple genes that have highly diverse functions. An important group of these genes are involved in cell cycle control. Thus, cyclin D1 is frequently overexpressed in a varety of human cancers. Cylin D1 plays a critical role in carcinogenesis because (i) overexpression enhances cell transformation and tumorigenesis, and enhances the amplification of other genes, and (ii) an antisense cyclin D1 cDNA reverts the malignant phenotype of carcinoma cells. Therefore, cyclin D1 may be a useful biomarker in molecular epidemiology studies, and inhibitors of its function may be useful in both cancer chemoprevention and therapy. We discovered a paradoxical increase in the cell cycle inhibitors protein p27(Kip1) in a subset of human cancers, and obtained evidence for homeostatic feedback loops between cyclins D1 or E and p27(Kip1). Furthermore, derivatives of HT29 colon cancer cells with increased levels of p27(Kip1) showed increased sensitivity to induction of differentiation. This may explain why decreased p27(Kip1) in a subset of human cancers is associated with a high grade (poorly differentiated) histology and poor prognosis. Agents that increase cellular levels of p27(Kip1) may, therefore, also be useful in cancer therapy. Using an antisense Rb oligonucleotide we obtained evidence that the paradoxical increase in pRb often seen in human colon cancers protects these cells from growth inhibition and apopotosis. On the basis of these, and other findings, we hypothesize that homeostatic feedback mechanisms play a critical role in multistage carcinogenesis. Furthermore, because of their bizarre circuitry, cancer cells suffer from 'gene addiction' and 'gene hypersensitivity' disorders that might be exploited in both cancer prevention and chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783304     DOI: 10.1093/carcin/21.5.857

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  62 in total

Review 1.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

Authors:  L Pignataro; G Sambataro; D Pagani; G Pruneri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes.

Authors:  Sreenath V Sharma; Patrycja Gajowniczek; Inna P Way; Diana Y Lee; Jane Jiang; Yuki Yuza; Marie Classon; Daniel A Haber; Jeffrey Settleman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Proteomic profiling identified multiple short-lived members of the central proteome as the direct targets of the addicted oncogenes in cancer cells.

Authors:  Tonggang Qi; Wei Zhang; Yun Luan; Feng Kong; Dawei Xu; Guanghui Cheng; Yunshan Wang
Journal:  Mol Cell Proteomics       Date:  2013-10-08       Impact factor: 5.911

4.  Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Authors:  Jason R Gee; Corrie B Burmeister; Thomas C Havighurst; Kyungmann Kim
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

5.  Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.

Authors:  Sandra S McAllister; Michelle Becker-Hapak; Giuseppe Pintucci; Michele Pagano; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 6.  Epidermal growth factor receptor first generation tyrosine-kinase inhibitors.

Authors:  Alex Martinez-Marti; Alejandro Navarro; Enriqueta Felip
Journal:  Transl Lung Cancer Res       Date:  2019-11

7.  PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.

Authors:  Marybeth A Pysz; Olga V Leontieva; Nicholas W Bateman; Joshua M Uronis; Kathryn J Curry; David W Threadgill; Klaus-Peter Janssen; Sylvie Robine; Anna Velcich; Leonard H Augenlicht; Adrian R Black; Jennifer D Black
Journal:  Exp Cell Res       Date:  2009-02-14       Impact factor: 3.905

8.  Differential expression of cyclin D1 in the human hair follicle.

Authors:  Xiaowei Xu; Stephen Lyle; Yaping Liu; Benjamin Solky; George Cotsarelis
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells.

Authors:  Dongyun Zhang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-14       Impact factor: 4.219

10.  Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.

Authors:  Jason M Foster; Uppala Radhakrishna; Venkatesh Govindarajan; Joseph H Carreau; Zoran Gatalica; Poonam Sharma; Swapan K Nath; Brian W Loggie
Journal:  World J Surg Oncol       Date:  2010-10-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.